An Overview of Chemistry, Kinetics, Toxicity and Therapeutic Potential of Boldine in Neurological Disorders

被引:6
作者
Akotkar, Likhit [1 ]
Aswar, Urmila [1 ]
Ganeshpurkar, Ankit [2 ]
Raj, Ritik [3 ]
Pawar, Atmaram [4 ]
机构
[1] Bharati Vidyapeeth Deemed Univ, Poona Coll Pharm, Dept Pharmacol, Pune 411038, Maharashtra, India
[2] Bharati Vidyapeeth Deemed Univ, Poona Coll Pharm, Dept Pharmaceut Chem, Pune 411038, India
[3] Bharati Vidyapeeth Deemed Univ, Poona Coll Pharm, Dept Pharmaceut Biotechnol, Pune 411038, India
[4] Bharati Vidyapeeth Deemed Univ, Poona Coll Pharm, Dept Pharmaceut, Pune 411038, India
关键词
Alkaloids; Antioxidant; Boldine; Aporphine; Neuroprotective; Toxicity; SPINAL-CORD-INJURY; MICROSOMAL LIPID-PEROXIDATION; OXIDATIVE STRESS; IN-VITRO; ALKALOID BOLDINE; PEUMUS-BOLDUS; ANTIOXIDANT ACTIVITY; APORPHINE ALKALOIDS; STATUS EPILEPTICUS; CELL-DEATH;
D O I
10.1007/s11064-023-03992-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Boldine is an alkaloid obtained from the medicinal herb Peumus boldus (Mol.) (Chilean boldo tree; boldo) and belongs to the family Monimiaceae. It exhibits a wide range of pharmacological effects such as antioxidant, anticancer, hepatoprotective, neuroprotective, and anti-diabetic properties. There is a dearth of information regarding its pharmacokinetics and toxicity in addition to its potential pharmacological activity. Boldine belongs to the aporphine alkaloid class and possesses lipophilic properties which enable its efficient absorption and distribution throughout the body, including the central nervous system. It exhibits potent free radical scavenging activity, thereby reducing oxidative stress and preventing neuronal damage. Through a variety of neuroprotective mechanisms, including suppression of AChE and BuChE activity, blocking of connexin-43 hemichannels, pannexin 1 channel, reduction of NF-& kappa;& beta; mediated interleukin release, and glutamate excitotoxicity which successfully reduces neuronal damage. These results point to its probable application in reducing neuroinflammation and oxidative stress in epilepsy, Alzheimer's disease (AD), and Parkinson's disease (PD). Moreover, its effects on serotonergic, dopaminergic, opioid, and cholinergic receptors were further investigated in order to determine its applicability for neurobehavioral dysfunctions. The article investigates the pharmacokinetics of boldine and reveals that it has a low oral bioavailability and a short half-life, requiring regular dosage to maintain therapeutic levels. The review studies boldine's potential therapeutic uses and mode of action while summarizing its neuroprotective benefits. Given the favorable results for boldine as a potential neurotherapeutic drug in laboratory animals, more research is required. However, in order to optimise its therapeutic potential, it must be more bioavailable with fewer detrimental side effects.
引用
收藏
页码:3283 / 3295
页数:13
相关论文
共 50 条
  • [1] An Overview of Chemistry, Kinetics, Toxicity and Therapeutic Potential of Boldine in Neurological Disorders
    Likhit Akotkar
    Urmila Aswar
    Ankit Ganeshpurkar
    Ritik Raj
    Atmaram Pawar
    Neurochemical Research, 2023, 48 : 3283 - 3295
  • [2] Therapeutic potential of naringin in neurological disorders
    Ahmed, Salman
    Khan, Haroon
    Aschner, Michael
    Hasan, Muhammad Mohtasheemul
    Hassan, Sherif T. S.
    FOOD AND CHEMICAL TOXICOLOGY, 2019, 132
  • [3] Neuroprotective Potential of Chrysin: Mechanistic Insights and Therapeutic Potential for Neurological Disorders
    Mishra, Awanish
    Mishra, Pragya Shakti
    Bandopadhyay, Ritam
    Khurana, Navneet
    Angelopoulou, Efthalia
    Paudel, Yam Nath
    Piperi, Christina
    MOLECULES, 2021, 26 (21):
  • [4] Harnessing Therapeutic Potentials of Biochanin A in Neurological Disorders: Pharmacokinetic and Pharmacodynamic Overview
    Kumar, Ankit
    Angelopoulou, Efthalia
    Pyrgelis, Efstratios-Stylianos
    Piperi, Christina
    Mishra, Awanish
    CHEMISTRY & BIODIVERSITY, 2024, 21 (08)
  • [5] Therapeutic Potential of Myricetin in the Treatment of Neurological, Neuropsychiatric, and Neurodegenerative Disorders
    Sethiya, Neeraj Kumar
    Ghiloria, Neha
    Srivastav, Akanksha
    Bisht, Dheeraj
    Chaudhary, Sushil Kumar
    Walia, Vaibhav
    Alam, Md. Sabir
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2024, 23 (07) : 865 - 882
  • [6] Macamides as Potential Therapeutic Agents in Neurological Disorders
    Vera-Lopez, Karin J.
    Davila-Del-Carpio, Gonzalo
    Nieto-Montesinos, Rita
    NEUROLOGY INTERNATIONAL, 2024, 16 (06): : 1611 - 1625
  • [7] Insights on therapeutic potential of clemastine in neurological disorders
    Jiang, Sufang
    Wang, Xueji
    Cao, Tianyu
    Kang, Rongtian
    Huang, Lining
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2023, 16
  • [8] Fatty acids and their therapeutic potential in neurological disorders
    Lei, Enie
    Vacy, Kristina
    Boon, Wah Chin
    NEUROCHEMISTRY INTERNATIONAL, 2016, 95 : 75 - 84
  • [9] Therapeutic potentials of crocin in medication of neurological disorders
    Ahmed, Salman
    Hasan, Muhammad Mohtasheemul
    Heydari, Mojtaba
    Rauf, Abdur
    Bawazeer, Saud
    Abu-Izneid, Tareq
    Rebezov, Maksim
    Shariati, Mohammad Ali
    Daglia, Maria
    Rengasamy, Kannan R. R.
    FOOD AND CHEMICAL TOXICOLOGY, 2020, 145
  • [10] Emergence of taurine as a therapeutic agent for neurological disorders
    Jangra, Ashok
    Gola, Priyanka
    Singh, Jiten
    Gond, Pooja
    Ghosh, Swarnabha
    Rachamalla, Mahesh
    Dey, Abhijit
    Iqbal, Danish
    Kamal, Mehnaz
    Sachdeva, Punya
    Jha, Saurabh Kumar
    Ojha, Shreesh
    Kumar, Dinesh
    Jha, Niraj Kumar
    Chopra, Hitesh
    Tan, Shing Cheng
    NEURAL REGENERATION RESEARCH, 2024, 19 (01) : 62 - 68